Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2023-08-25 00:00:00 ET · period of report 2023-08-23 · accession 0001968202-23-000028 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-08-25 | 2023-08-24 | REGN | Van Plew Daniel P | EVP, General Mgr, Industrial | S - Sale+OE | $841.71 | -6,197 | 27.6K | -18% | -$5.22M |
| D | 2023-08-25 | 2023-08-23 | REGN | Van Plew Daniel P | EVP, General Mgr, Industrial | M - OptEx | $381.40 | +23.1K | 44.6K | +108% | +$8.82M |
| D | 2023-08-25 | 2023-08-23 | REGN | Van Plew Daniel P | EVP, General Mgr, Industrial | F - Tax | $842.66 | -16.9K | 27.7K | -38% | -$14.26M |
| D | 2023-08-25 | 2023-08-23 | REGN | Van Plew Daniel P | EVP, General Mgr, Industrial | M - OptEx | $0.00 | -23.1K | 23.1K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-24 | S | D | 2,534 | $844.27 | 21,508 | D | — | — | (F8) Represents volume-weighted average price of sales of 2,534 shares of Company stock on August 24, 2023 at prices ranging from $844.02 to $844.46. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 24, 2023 at each separate price. |
| 2 | Common | Common Stock | 2023-08-23 | M | A | 23,125 | $381.40 | 44,633 | D | — | — | |
| 3 | Common | Common Stock | 2023-08-24 | S | D | 759 | $843.31 | 24,042 | D | — | — | (F7) Represents volume-weighted average price of sales of 759 shares of Company stock on August 24, 2023 at prices ranging from $843.04 to $843.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 24, 2023 at each separate price. |
| 4 | Common | Common Stock | 2023-08-24 | S | D | 617 | $842.66 | 24,801 | D | — | — | (F6) Represents volume-weighted average price of sales of 617 shares of Company stock on August 24, 2023 at prices ranging from $842.28 to $842.77. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 24, 2023 at each separate price. |
| 5 | Common | Common Stock | 2023-08-24 | S | D | 363 | $841.15 | 25,418 | D | — | — | (F5) Represents volume-weighted average price of sales of 363 shares of Company stock on August 24, 2023 at prices ranging from $841.03 to $841.83. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 24, 2023 at each separate price. |
| 6 | Common | Common Stock | 2023-08-24 | S | D | 46 | $840.74 | 25,781 | D | — | — | |
| 7 | Common | Common Stock | 2023-08-24 | S | D | 148 | $839.28 | 25,827 | D | — | — | (F4) Represents volume-weighted average price of sales of 148 shares of Company stock on August 24, 2023 at prices ranging from $839.08 to $839.37. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 24, 2023 at each separate price. |
| 8 | Common | Common Stock | 2023-08-24 | S | D | 667 | $838.37 | 25,975 | D | — | — | (F3) Represents volume-weighted average price of sales of 667 shares of Company stock on August 24, 2023 at prices ranging from $838.06 to $838.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 24, 2023 at each separate price. |
| 9 | Common | Common Stock | 2023-08-24 | S | D | 300 | $837.53 | 26,642 | D | — | — | |
| 10 | Common | Common Stock | 2023-08-24 | S | D | 625 | $836.32 | 26,942 | D | — | — | (F2) Represents volume-weighted average price of sales of 625 shares of Company stock on August 24, 2023 at prices ranging from $836.10 to $836.53. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 24, 2023 at each separate price. |
| 11 | Common | Common Stock | 2023-08-23 | F | D | 16,928 | $842.66 | 27,705 | D | — | — | |
| 12 | Common | Common Stock | 2023-08-24 | S | D | 138 | $835.67 | 27,567 | D | — | — | (F1) Represents volume-weighted average price of sales of 138 shares of Company stock on August 24, 2023 at prices ranging from $835.58 to $835.85. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 24, 2023 at each separate price. |
| 13 | Derivative | Non-Qualified Stock Option (right to buy) | 2023-08-23 | M | D | 23,125 | $0.00 | 23,125 | D | $381.40 · — to 2028-12-12 | 23,125 Common Stock | (F9) The stock option award vests in four equal annual installments, commencing one year after the date of grant. |